MG
MDVL

Michael Gelband’s MedAvail Holdings, Inc. Common Stock MDVL Stock Holding History

Michael Gelband’s Portfolio MDVL Stock Details MDVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-626
Closed -$471K – 2723
2020
Q4 		$471K Buy
+626
New +$437K ﹤0.01% 1291

Other funds holding MDVL

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
AWGLSCP
ABG-WTT Global Life Science Capital Partners Central, Hong Kong, Hong Kong $8.55M AUM 12.76% 1-Year Est. Return
ABG
Ally Bridge Group New York $113M AUM 245.92% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CI
Cigna Investments Bloomfield, Connecticut $773M AUM 44.02% 1-Year Est. Return
MS
Maven Securities St Helier, Jersey $5.06B AUM 59.27% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $59.6M AUM 181.61% 1-Year Est. Return

Michael Gelband's MDVL Position: Q1 2021 in Review

Michael Gelband sold out of MedAvail Holdings, Inc. Common Stock (MDVL) in Q1 2021, closing a stake of 626 shares — an estimated $471K sold.

Michael Gelband first reported a position in MDVL in Q4 2020 and held it in 1 quarter. The position peaked at $471K in Q4 2020. 33 funds tracked by Wall St. Rank hold MDVL as of Q1 2021.

  • Michael Gelband reported no remaining MedAvail Holdings, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Michael Gelband sold 626 MedAvail Holdings, Inc. Common Stock shares in Q1 2021, an estimated $471K.
  • Michael Gelband first reported a position in MedAvail Holdings, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Michael Gelband's MedAvail Holdings, Inc. Common Stock position peaked at $471K in Q4 2020.
  • 33 funds tracked by Wall St. Rank held MedAvail Holdings, Inc. Common Stock as of Q1 2021.

Based on ExodusPoint Capital Management's 13F filing for Q1 2021, filed 17 May 2021.